In this respiratory disease roundup, experts examine the rising cases of human metapneumovirus in China, new research on COVID-19’s long-term effects on kidney function, the effectiveness of...
In this respiratory disease roundup, experts discuss the rising concerns over new cases of avian influenza in young people, the FDA's emergency approval of pemivibart monoclonal antibody for COVID-19, the...
A recent phase 3b long-term extension study assessed the safety and efficacy of deucravacitinib over 2 years in patients with moderate-to-severe plaque psoriasis.
This respiratory health roundup highlights the emerging links between lung and brain health in long COVID, rising avian flu cases in humans and animals, additional insights into the lasting health impacts...
A new study finds similar in-hospital mortality rates for health care-associated COVID-19 and influenza, highlighting the ongoing clinical burden of both diseases in hospitalized patients.
A large cohort study from the Czech Republic suggests that molnupiravir reduced both all-cause and COVID-19-related mortality in adult patients during the Omicron outbreak.
Researchers with the American Gastroenterological Association (AGA) release a comprehensive set of guidelines on the use of biomarkers for monitoring and managing Crohn disease in patients.
Researchers set out to compare the time until the next treatment in patients with chronic lymphocytic leukemia who are treated with single-agent ibrutinib at a sustained dose of 420 mg/day vs patients who...
The Work Group from the Kidney Disease: Improving Global Outcomes organization updated its set of guidelines that offers clinical practice guidelines in the treatment of chronic kidney disease and...
